key: cord-0686515-zgym82g9
authors: CHERVENAK, Frank A.; McCULLOUGH, Laurence B.; BORNSTEIN, Eran; JOHNSON, Lisa; KATZ, Adi; McLEOD-SORDJAN, Renee; NIMAROFF, Michael; ROCHELSON, Burton L.; Asma TEKBALI, Ms.; Ashley WARMAN, Ms.; WILLIAMS, Kim; GRÜNEBAUM, Amos
title: Professionally Responsible COVID-19 Vaccination Counseling of Obstetric/Gynecologic Patients Counseling Patients about COVID-19 Vaccination
date: 2021-02-01
journal: Am J Obstet Gynecol
DOI: 10.1016/j.ajog.2021.01.027
sha: 2ca54ce1d7cc5fc2249b36de4273fb96800c2e88
doc_id: 686515
cord_uid: zgym82g9

The development of COVID-19 vaccines in current and planned clinical trials is essential for the success of this public health response. This paper focuses on how physicians should implement the results of these clinical trials: counseling patients who are pregnant, planning to become pregnant, breastfeeding or planning to breastfeed about vaccines with government authorization for clinical use. Determining the most effective approach to counseling patients about COVID-19 vaccination is challenging. We address the professionally responsible counseling of three groups of patients – those who are pregnant, those planning to become pregnant, and those breastfeeding or planning to breastfeed. We begin with an evidence-based account of five major challenges: the limited evidence base; documented increased risk of severe disease among pregnant COVID-19-infected patients; conflicting guidance from government agencies and professional associations; false information about COVID-19 vaccines; and maternal mistrust and vaccine hesitancy. We then provide evidence-based, ethically justified, practical guidance for meeting these challenges in professionally responsible counseling of patients about COVID-19 vaccination. To guide professionally responsible counseling of patients who are pregnant, planning to become pregnant, and breastfeeding or planning to breastfeed, we explain how obstetrician-gynecologists should evaluate current clinical information and why a recommendation of COVID-19 vaccination should be made and how this assessment should be presented to patients in the informed consent process with the goal of empowering them to make informed decisions. We also present a pro-active account of how to respond when patients refuse recommended vaccination, the elements of which are the legal obligation of informed refusal and the ethical obligation to ask patients to reconsider. During this process, the physician should be alert to vaccine hesitancy, ask patients to express their hesitation and reasons for it, and respectfully address them. In contrast to the conflicting guidance from government agencies and professional associations, evidence-based professional ethics in obstetrics and gynecology provides unequivocal and clear guidance: The physician should recommend COVID-19 vaccination to patients who are pregnant, planning to become pregnant, and breastfeeding or planning to breastfeed. To prevent widening health inequities, to build trust in the health benefits of vaccination and to encourage COVID-19 vaccine and treatment uptake, in addition to recommending COVID-19 vaccinations, physicians should engage with communities to tailor strategies to overcome mistrust and deliver evidence-based information, robust educational campaigns and novel approaches to immunization.

The development of COVID-19 vaccines in current and planned clinical trials is essential for the success of this public health response. This paper focuses on how physicians should implement the results of these clinical trials: counseling patients who are pregnant, planning to become pregnant, breastfeeding or planning to breastfeed about vaccines with government authorization for clinical use. Determining the most effective approach to counseling patients about COVID-19 vaccination is challenging. We address the professionally responsible counseling of three groups of patients -those who are pregnant, those planning to become pregnant, and those breastfeeding or planning to breastfeed. We begin with an evidence-based account of five major challenges: the limited evidence base; documented increased risk of severe disease among pregnant COVID-19-infected patients; conflicting guidance from government agencies and professional associations; false information about COVID-19 vaccines; and maternal mistrust and vaccine hesitancy. We then provide evidence-based, ethically justified, practical guidance for meeting these challenges in professionally responsible counseling of patients about COVID-19 vaccination. To guide professionally responsible counseling of patients who are pregnant, planning to become pregnant, and breastfeeding or planning to breastfeed, we explain how obstetrician-gynecologists should evaluate current clinical information and why a recommendation of COVID-19 vaccination should be made and how this assessment should be presented to patients in the informed consent process with the goal of empowering them to make informed decisions. We also present a pro-active account of how to respond when patients refuse recommended vaccination, the elements of which are the legal obligation of informed refusal and the ethical obligation to ask patients to reconsider. During this process, the physician should be alert to vaccine hesitancy, ask patients to express their J o u r n a l P r e -p r o o f guidance from government agencies and professional associations, evidence-based professional ethics in obstetrics and gynecology provides unequivocal and clear guidance: The physician should recommend COVID-19 vaccination to patients who are pregnant, planning to become pregnant, and breastfeeding or planning to breastfeed. To prevent widening health inequities, to build trust in the health benefits of vaccination and to encourage COVID-19 vaccine and treatment uptake, in addition to recommending COVID-19 vaccinations, physicians should engage with communities to tailor strategies to overcome mistrust and deliver evidence-based information, robust educational campaigns and novel approaches to immunization.

The COVID-19 pandemic has created a global health crisis that requires effective prevention and treatment on an unprecedented scale. The development of COVID- 19 Determining the most effective approach to this conversation is challenging. In this clinical opinion, we identify five major challenges and provide evidence-based, ethically justified, practical guidance for meeting these challenges in counseling patients about COVID-19 vaccination. Our aim is to be both clinically applicable and sensitive to patients' concerns. We therefore address the counseling of three groups of patients -those who are pregnant, those planning to become pregnant, and those breastfeeding or planning to breastfeed.

There is currently little evidence from clinical trials about the safety and efficacy of the COVID-19 vaccine in pregnancy because pregnant women have been excluded from these vaccine trials. The theoretical risk of the COVID-19 vaccine must be assessed in context of the documented increased risk of severe COVID-19 disease to both maternal and fetal health. 4 Immunization with inactivated vaccines or toxoids during pregnancy is not expected to be associated with an increased risk to the pregnant patient or the fetus. 5, 6 In an overview of 17 J o u r n a l P r e -p r o o f systematic reviews reporting maternal-fetal and neonatal outcomes after immunizations during pregnancy, no major safety concerns have been identified and risks were not identified for any vaccine or outcome of interest. 7 Statements from governments and professional associations are inconsistent. False information and rumors abound. Some patients hesitate to become vaccinated; others refuse vaccination.

Counseling pregnant patients about the efficacy and safety of COVID-19 vaccination confronts the challenge that the clinical trials for currently available vaccines excluded pregnant patients. This is a common exclusion in vaccine and drug trials. A contributing reason for this exclusion is likely legal rather than ethical: vaccine and drug manufacturers might expose themselves to liability to injury to fetuses and future children that is alleged to have resulted from receiving a vaccine or drug as a subject in a clinical trial. Vaccine and drug manufacturers have a corporate interest in preventing such liability. This obstacle could be removed by legislation addressing clinical trial participation, which is long overdue. Such a policy change, however, is unlikely to occur soon enough for continuing or new COVID-19 vaccine trials.

The exclusion of pregnant patients from clinical vaccine trials results in lack of data from a clinical trial arm that would provide trials-based evidence for assessing both the efficacy and safety of COVID-19 vaccination for pregnant patients and their offspring. To date, there are no efficacy or safety data specific to the COVID mRNA vaccine use in pregnant or lactating patients. Therefore, based on the absence of actual trial data, the risks to pregnant and fetal patients are unknown. There is, however, a large direct evidence base about potential safety from the experience of subjects in the treatment arms of trials and also from past experience with nonlive vaccines. There is also indirect evidence. The mRNA vaccines are not live-virus vaccines.

J o u r n a l P r e -p r o o f They do not use an adjuvant to enhance vaccine efficacy. In addition, mRNA vaccines do not enter the nucleus and do not alter human DNA in vaccine recipients. As a result, "..the mRNA strand never enters the cell's nucleus or affects genetic material..". 8 and mRNA is unlikely to cross the placenta. In studies on mice vaccinated against ZIKA, mRNA was shown to protect against placental damage. 9 This evidence suggests that the probable hypothesis is that current are reports of more severe disease and other pregnancy complications. 13, 14, 15, 16, 17, 18, 19 There is therefore an increased potential for maternal deaths, 20, 21, 22, 23 especially in low-to middle-income countries. 24 There are disparate accounts of an increase in preterm births, 23,25,26,27 and an increase in preterm cesarean deliveries, 28 myocardial injuries, 29, 30 as well as increased risks in J o u r n a l P r e -p r o o f preeclampsia, cesarean delivery, and perinatal death. 31 Compared to COVID-19 infected nonpregnant peers, symptomatic pregnant patients may be at increased risk of more severe COVID-19 disease. 32 Kim et al. reported an increased case fatality rate of critically ill pregnant patients, 33 although there is variable information on ICU admissions for COVID-19 pregnant patients, 25, 34, 35 Vertical transmission of severe acute respiratory syndrome coronavirus 2 from the mother to the fetus has also been reported. 36, 37 In addition, coronavirus disease has been found to be associated with placental inflammation and histopathologic abnormalities, fetal vascular malperfusion and villitis, suggesting that the virus could impact perinatal outcomes through placental injury with possible adverse effects in the neonates. 38, 39 Black and Hispanic pregnant patients appear to be disproportionately affected by SARS-CoV-2 infection not only during pregnancy with increased risk for intensive care unit admissions and receipt of mechanical ventilation, but not death. 32, 40, 41 Finally, Saccone et al. 43 reported that among pregnant women, more than half of the respondents rated the psychological impact of the COVID-19 outbreak as severe, and about two-thirds reported higher than normal anxiety.

International government agencies and professional associations in Asia, Europe, the Middle East, and North American, as well as the World Health Organization take differing positions. (Table 1 ) Positions differ on both scientific and ethical grounds.

Some take an approach based on the ethical principle of respect for autonomy. (Table 2) The CDC in the United States appeals implicitly to this ethical principle: information should be provided and patients' questions addressed but no recommendations made. 1 The American

College of Obstetricians and Gynecologists takes a similar position. 2 J o u r n a l P r e -p r o o f Canada 47 and Ireland 51 state that the physician should explain that the risk-benefit ratio favors vaccination and that it should be offered. These positions assume that vaccination is not contraindicated for pregnant patients, i.e., the clinical benefits outweigh the risks. The precautionary principle is not violated. (Table 2) . Therefore, according to these two recommendations, patients should decide for themselves, without a recommendation being made.

Others take beneficence-based approaches and come to different conclusions. (Table 2) Austria 48 states that vaccination is contraindicated for pregnancy and breastfeeding patients and that vaccination of partners of pregnant patients should be a priority. France 49 , The Netherlands 53 , and Japan 55 take the position that vaccination should not be recommended in pregnancy. These positions assume that the risk/benefit ratio of vaccination of pregnant patients is unfavorable and violates the precautionary principle.

By contrast, Germany 50 and The United Kingdom 52 take the position that vaccination should be offered only after risk assessment. This position assumes that the risk/benefit ratio is favorable and therefore that the precautionary principle is not violated. The current evidence base supports recommending vaccination. Israel states that "… priority will now be given to breastfeeding women, pregnant women and women who are planning to get pregnant." 54

The World Health Organization 56 takes the position that there are insufficient data upon which to provide guidance. Guidance should be delayed until the evidence base permits a more definitive assessment of the risk/benefit ratio. This position invokes the precautionary principle to manage uncertainty.

It is a disturbing reality that there is an abundance of false information available on the The informed consent process empowers the patient to make informed decisions when that process is based on her values and beliefs. 59 To support patients, they can be asked what is important to them, a question that has been shown to elicit the patients' values. 62 Patients should also be asked to express any concerns they might have. The physician should listen attentively and respond to mistaken or incomplete information with a respectful explanation of what is known and the crucial distinction between documented and theoretical risks. Making a recommendation, as explained below, may help to allay patients' concerns.

The informed consent process should be tailored to each of the three groups of patients.

For each, we identify relevant clinical information and how it should be evaluated by the physician and, on this basis, how patients should be empowered to make informed decisions.

The Physician's Evaluation. When counselling patients, physicians should use available data to weigh the benefits and risks of COVID-19 vaccines. 63 In evidence-based clinical judgment, documented benefits and risks of COVID-19 vaccination for pregnant patients count more than theoretical risks and harms. The benefit of vaccination is prevention of COVID-19 infection and consequently severe disease and mortality, as well as preventing transmission of COVID-19 to others. The risk of non-vaccination is not only severe COVID-19 and increased mortality, but also transmitting the virus to others. The complications of vaccination with COVID-19 have been documented to be rare and clinically manageable. The fetal patient is not exposed to documented risk, based on indirect evidence, nor is the breastfed newborn. 4,5,7 mRNA is unlikely to cross the placenta and in mice models mRNA Zika vaccine has been shown to J o u r n a l P r e -p r o o f protect the placenta. 8 Theoretical risks should not shape the informed consent process and the physician's evaluation that, on balance, COVID-19 vaccination confers significant clinical benefit. There is a consensus that receiving a recommendation from a health care provider for vaccination is the most important factor in maternal decision-making, irrespective of geographic or social context. 64 

Empowering Patients to Make Informed Decisions. The patient should be told that there is no evidence of harm to her baby from breast feeding after vaccination and there could be possible benefits to the newborn. Vaccination should be recommended.

The Physician's Evaluation. Patients' information needs may differ. Some patients planning to become pregnant may hesitate to accept vaccination. The reasons for vaccine hesitancy vary from person to person and community to community. Others may express concern or rejection based on false beliefs.

The physician's response should be professional, not personal. These patients should be treated with respect, especially attentive to patients influenced by false information that is now circulating on internet sites that the patient may visited or been told about by others. Physicians should keep in mind that memory is created by repetition, independent of whether what is repeated is true. This has the important implication that the physician should eschew prejudicial views about patients who express false beliefs. Instead, the physician should respond to a patient in need, in this case, in need of accurate information.

Other patients do not espouse false beliefs but are prudent in being risk averse about their planned pregnancies. Prudence is a virtue that calls for a patient to identify her legitimate selfinterests, short-term and long-term, and act to protect them. Prudential judgments should be evidence-based. Current evidence supports the view that legitimate self-interest in health and life are supported by timely vaccination. The physician should point this out and ask patients to reconsider their judgments. Research regarding prior pandemics has supported that healthcare professional recommendation for maternal vaccination is an important factor influencing behavior. 69 

In ethical theory patients who want others to be vaccinated but not themselves and who therefore want the benefits of herd immunity without vaccination are known as "free riders." This is a general problem with vaccination, including childhood vaccination. 70 The decision to be a free rider does not command respect because free riders want others to take risks without having to take those risks themselves. The physician should point this out and ask patients if they think that this is fair to those who do accept vaccination. Offering the patients to consider this question empowers them to make an informed and responsible decision.

There is no evidence that vaccination affects present or future fertility and the ASRM recommends that eligible patients who are planning to become pregnant should be vaccinated. 46 Patients planning to become pregnant typically do not want to impede their fertility and want the best outcomes for their pregnancies to themselves and their babies. Having false beliefs is incompatible with valuing these goals.

Empowering Patients to Make Informed Decisions. The goal should be empowering patients to recognize that they have mistakenly adopted false beliefs that, if acted on, would jeopardize their goals for their planned pregnancy. For patients invoking prudence, the physician should educate them as described above. The goal should be a patient who recognizes that her prudential judgment is not evidence-based. For free riders, the physician should ask them to reconsider as described above. The goal should be a patient who understands that the responsible decision is to become vaccinated.

Despite education, some patients for whom there are no contraindications for vaccination will refuse recommended vaccination. It is essential that their refusal not be taken personally by the physician and that conversation with them be respectful.

This is especially important in responding to decisions against vaccination by patients of color. Their vaccine hesitancy or resistance may reflect both personal and community history of mistreatment.

Patient refusal of COVID-19 vaccination may be based on the fact that, as the CDC has stated, "... there are currently few data on the safety of COVID-19 vaccines, including mRNA vaccines, in pregnant people ..." 1 and by ACOG: "there are no safety data specific to use in pregnancy." 2 This information is being used in some countries to deny pregnant women the opportunity to accept vaccination. (Table 1 ) No pregnant patient wants to do anything "unsafe".

When these statements are repeated during a counseling session, they may sound potentially scary, but using the term "safety" is too non-specific as to what it means in the context of COVID-19 vaccination in pregnancy.

The physician should put absence of safety data in pregnancy in its proper perspective.

We know that giving COVID-19 vaccines to pregnant women will be effective in preventing COVID-19 disease; that without the vaccine pregnant women are more likely to get sick, be admitted to intensive care, and possibly die if they become infected; that adverse pregnancy outcomes, such as preterm births, are not more likely to occur because of the vaccine; and that the fetus is not more likely to have an adverse outcome because of the vaccine.

The American College of Obstetricians and Gynecologists states that " … pregnant patients who refuse the vaccine should be supported in their decision." 2 This can be read to suggest that the physician should simply accept a patient's refusal, which is not an adequate response. The physician has a strict legal obligation to satisfy the requirements of what is known as informed refusal. 59 Patients should be informed about the risks that they are taking for 

Evidence-based professional ethics in obstetrics and gynecology provides unequivocal and clear guidance. 59, 60 There is evidence that a health care provider's recommendation for vaccination is the most important factor in maternal decision-making, irrespective of geographic or social context. [64] [65] [66] [67] [68] [69] Physicians should use available data to weigh the benefits and risks of COVID-19 vaccines 63 and consequently they should recommend COVID-19 vaccination to all patients planning to become pregnant, all pregnant patients, and all patients who are breastfeeding or planning to breastfeed. Rather than using disease threat alone when recommending a vaccine, public health campaigns which center on the protectiveness and safety of a maternal vaccine may prove beneficial. 70 Minorities and especially African American patients continue to experience low vaccination uptake, stemming, at least in part, from years of bias in and mistrust of orthodox medicine, safety concerns, and environmental barriers to vaccine access. 71 To prevent widening health inequities, to build trust in the health benefits of vaccination and to encourage COVID-19 vaccine and treatment uptake, in addition to recommending COVID-19 vaccinations, physicians should engage with communities to tailor J o u r n a l P r e -p r o o f strategies to overcome mistrust and deliver evidence-based information, robust educational campaigns and novel approaches to influenza immunization. 71, 72 Some statements from governments and professional associations concerning COVID-19 vaccinations implicitly adopt the approach of shared decision making, a phrase often used without precision. Shared decision making means that the physician should present information but make no recommendation. 73 previously said that pregnant women should not be immunized, now says (as of 12/30/2020) that: "Although the available data do not indicate any safety concern or harm to pregnancy, there is insufficient evidence to recommend routine use of COVID-19 vaccines during pregnancy" and "..the JCVI now advises that if a pregnant woman meets the definition of being clinically extremely vulnerable, then she should discuss the options of COVID-19 vaccination with her obstetrician and/or doctor. This is because their underlying condition may put them at very high risk of experiencing serious complications of COVID-19." 52

The Netherlands: The National Institute for Public Health and the Environment of the Ministry of health, Welfare, and Sport states: "Are you pregnant? If so, it is recommended to postpone the vaccination until after your pregnancy." 53 Middle East Israel: "Priority will now be given to breastfeeding women, pregnant women and women who are planning to get pregnant." 54 Asia Japan: "Pregnant women will not be given vaccination priority due to insufficient knowledge about vaccine safety and effectiveness for them." 55

The World Health Organization (WHO) states that "Guidance on pregnant women in groups prioritized for vaccination before these urgently needed safety data are available will need to await information about the specific characteristics of the vaccines authorized for use, as well as the latest evidence on risks of COVID-19 for pregnant women and their children. 56 J o u r n a l P r e -p r o o f Precautionary: A "longstanding principle of public health: when in doubt about danger, we should err on the side of caution" by preventing danger. 57

COVID-19 Vaccines in Pregnancy

Global Advisory Committee on Vaccine Safety. Safety of Immunization during Pregnancy A review of the evidence: World Health Organization

Pan American Health Organization. The Maternal and Neonatal Immunization Field Guide for Latin America and the Caribbean recommends the administration of Influenza (inactivated) and Tetanus/diphtheria vaccines

Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews

Modified mRNA Vaccines Protect against

Erratum for: Cell

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy

Coronavirus Disease 2019 in Pregnancy: The Experience at an Urban Safety Net Hospital

Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know

Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes

Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls

Acute Pancreatitis in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)

Multisystem Inflammatory Syndrome in a Pregnant Woman

Epub ahead of print

Clinical Presentation of Coronavirus Disease 2019 J o u r n a l P r e -p r o o f (COVID-19) in Pregnant and Recently Pregnant People

COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries

Maternal death due to COVID-19

Young pregnant women are also at an increased risk of mortality and severe illness due to COVID-19: Analysis of the Mexican National Surveillance Program

Maternal mortality among women with coronavirus disease 2019 admitted to the intensive care unit

Maternal deaths with coronavirus disease 2019: a different outcome from low-to middle-resource countries?

Maternal and Neonatal Characteristics and Outcomes of COVID-19 in Pregnancy: An Overview of Systematic Reviews

Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth

Singleton preterm birth rates for racial and ethnic groups during the coronavirus disease 2019 pandemic in California

Epub ahead of print

Coronavirus disease 2019 during pregnancy: a systematic review of reported cases

Myocardial injury associated with coronavirus disease 2019 in pregnancy

New-onset myocardial injury in pregnant patients with coronavirus disease 2019: a case series of 15 patients

Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and metaanalysis

Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status -United States

Maternal outcome of pregnant women admitted to intensive care units for coronavirus disease

Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease

Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status -United States

Response Pregnancy and Infant Linked Outcomes Team. MMWR Morb Mortal Wkly J o u r n a l P r e

SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes

Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis

Coronavirus disease 2019 infection and placental histopathology in women delivering at term

Dysregulated immunity in SARS-CoV-2 infected pregnant women

Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA. Emerg Infect Dis

Influence of Race and Ethnicity on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Rates and Clinical Outcomes in Pregnancy

Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations

Psychological impact of coronavirus disease 2019 in pregnant women

Accessed 1-11-2021

The professional responsibility model of obstetrical ethics: avoiding the perils of clashing rights

Academic physicians as factory workers: identifying and preventing alienation of labor

Mapping personal, familial, and professional values in long-term care decisions

Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know

Understanding factors influencing vaccination acceptance during pregnancy globally: A literature review

Predictors of maternal vaccination in the United States: An integrative review of the literature

Understanding barriers and predictors of maternal immunization: Identifying gaps through an exploratory literature review. Vaccine

A systematic review of barriers to vaccination during pregnancy in the Canadian context

Determinants of uptake of influenza vaccination among pregnant women-A systematic review

Factors that influence vaccination decisionmaking among pregnant women: A systematic review and meta-analysis

Professional Responsibility and Early Childhood Vaccination

The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans

COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV

The unlimited-rights model of obstetric ethics threatens professionalism